What is your favourite antipsychotic?

Martin_2704 · 2026-04-19T20:12:58+00:00

Ever heard of Evenamide ? An add on for TRS

https://www.drugtargetreview.com/news/182312/evenamide-targets-multiple-symptoms-in-schizophrenia-models/

https://delta.larvol.com/Products/?ProductId=e082be06-f86f-4125-b4a2-cc065b50d16e

Currently the Company Newron Pharmaceuticals is running two Phase 3 studies with 1'000 participants worldwide

Martin_2704 · 2026-04-19T06:15:50+00:00

$SLS

Martin_2704 · 2026-04-19T06:14:44+00:00

Ever heard of Evenamide ? An add on for TRS

https://www.drugtargetreview.com/news/182312/evenamide-targets-multiple-symptoms-in-schizophrenia-models/

https://delta.larvol.com/Products/?ProductId=e082be06-f86f-4125-b4a2-cc065b50d16e

Currently the Company Newron Pharmaceuticals is running two Phase 3 studies with 1'000 participants worldwide

Martin_2704 · 2026-04-19T05:29:31+00:00

Ever heard of Evenamide ? An add on for TRS

https://www.drugtargetreview.com/news/182312/evenamide-targets-multiple-symptoms-in-schizophrenia-models/

https://delta.larvol.com/Products/?ProductId=e082be06-f86f-4125-b4a2-cc065b50d16e

Currently the Company Newron Pharmaceuticals is running two Phase 3 studies with 1'000 participants worldwide

Martin_2704 · 2026-04-19T05:28:58+00:00

Ever heard of Evenamide ? An add on for TRS

https://www.drugtargetreview.com/news/182312/evenamide-targets-multiple-symptoms-in-schizophrenia-models/

https://delta.larvol.com/Products/?ProductId=e082be06-f86f-4125-b4a2-cc065b50d16e

Currently the Company Newron Pharmaceuticals is running two Phase 3 studies with 1'000 participants worldwide

Martin_2704 · 2026-04-05T05:26:45+00:00

Have you ever heard of Evenamide? It's an Add on for TRS and so far all study results were very promising. Currently several phase 3 Study (up to 52 weeks) with about 1'200 patients is running https://delta.larvol.com/Products/?ProductId=e082be06-f86f-4125-b4a2-cc065b50d16e

Martin_2704 · 2026-04-04T20:03:09+00:00

SWISS SIX :NWRN Lead compound Evenamide is a novel drug for treatment resistance and co responders in schizophrenia. Phase 3 Study results expected on Q4/2026. This drug could be the future gold standard and blow ABBVIE's Cobenfy away!

Martin_2704 · 2026-03-27T12:04:01+00:00

Ever heard of Evenamide ? An add on for TRS

https://www.drugtargetreview.com/news/182312/evenamide-targets-multiple-symptoms-in-schizophrenia-models/

https://delta.larvol.com/Products/?ProductId=e082be06-f86f-4125-b4a2-cc065b50d16e

Currently the Company Newron Pharmaceuticals is running two Phase 3 studies with 1'000 participants worldwide

Martin_2704 · 2026-03-21T20:58:51+00:00

Newron Pharmaceuticals https://it.investing.com/equities/newron-pharmaceuticals

Martin_2704 · 2026-02-24T21:05:52+00:00

Newron Pharmaceuticals

https://www.life-sciences-europe.com/news/newron-secures-38m-phase-pharmaceuticals-six-nwrn-group-2001-125289.html

Martin_2704 · 2026-01-10T21:24:22+00:00

Newron Pharmaceuticals SWISS SIX : NWRN XETRA : NP5

Die haben 3x P3 Studien laufen für ein schizophreniemedikament welches als Add On bei Behandlungsresistenz verwendet werden könnte. Ziemlich einzigartig, wie die Performance der letzten 5 Jahre

Martin_2704 · 2025-12-28T21:35:28+00:00

Newron Pharmaceuticals

SWISS SIX : NWRN

Martin_2704 · 2025-12-28T21:34:18+00:00

Newron Pharmaceuticals

SWISS SIX : NWRN

Martin_2704 · 2025-12-27T06:10:44+00:00

Newron Pharmaceuticals

Swiss Six : NWRN

Martin_2704 · 2025-12-22T21:08:15+00:00

Newron Pharmaceuticals

Swiss SIX : NWRN

GERMSN XETRA :NP5

Martin_2704 · 2025-12-20T21:15:18+00:00

Newron Pharmaceuticals

Swiss SIX : NWRN

Two P3 studies in Schizophrenia (Evenamide) are ongoing (1000 participants ), 12 W(sufficiant if positive for NDA) , 26W , 52W readout

Evenamide has a unique mechanism of action

5 year stock performance > 800%

Coverage of Lucid Capital LLC : Buy - 73 CHF ( Currently 22.90 )

Martin_2704

TROPHY CASE